skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon
The issue of reporting bias is well-known and non-publication of clinical trial results is unfortunately common. Various initiatives have been implemented to remedy this issue such as the FDA Amendments act in September 2007, which requires submission of results to a publicly accessible database within 12 months of study completion. However, this act only applies to a subset of Phase II-IV trials and not all clinical research.





電話:+81 (0)3 6273 4260